The Centre for Doctoral Training (CDT) is a partnership between University College London, the University of Nottingham, and SSPC - the Science Foundation Ireland Research Centre for Pharmaceuticals.

The CDT provides world-class PhD training to early career researchers. Our graduates have the knowledge and skill to take active molecules from drug discovery and design, and transform them into medicines to treat patients.

Funded by the Engineering and Physical Sciences Council in the UK, Science Foundation Ireland and a total of 19 industry partners, we provide world-leading training to prepare scientists for high achieving careers in the pharmaceutical and healthcare sectors.

Academic Supervisors

Students in the CDT who are funded by the SSPC are based in one of 3 universities in Ireland: Trinity College Dublin, UCD or UCC. Their research is supervised by an academic member of staff for 4 years of their PhD

Prof. Anne Marie Healy, CDT Co-Director/Principal Investigator School of Pharmacy, Trinity College Dublin / Twitter: @amhamon

person Full Profile

Anne Marie Healy is Professor of Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin and is one of the Co-Directors of the Centre for Doctoral Training in Transformative Pharmaceutical Technologies. She is also Co-Principal Investigator of SSPC - the Science Foundation Ireland Research Centre for Pharmaceuticals, and was awarded the SSPC Researcher of the Year in 2019. This award recognises Anne Marie’s many contributions to the Centre with exceptional scientific outputs.

Her research interests include pharmaceutical material science, preformulation and formulation of pharmaceuticals, amorphous solids, co-crystals, formulating poorly soluble drugs, pharmaceutical processing and pulmonary drug delivery.

Dr Abina Crean, Senior Lecturer in Pharmaceutics School of Pharmacy, University College Cork / Athena Swan Steering Committee Member / Twitter: @Abina

https://research.ucc.ie/profiles/a.crean@ucc.ie

Dr Abina Crean graduated with a degree in Pharmacy from Robert Gordon's University, Aberdeen, Scotland in 1992. In 1997, she completed a PhD in Pharmaceutics in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin. Abina worked as a formulation scientist with Elan Pharmaceutical Technologies and as a Process Development Pharmacist at Servier (Ireland) Industries. Since joining the School of Pharmacy in UCC in 2003, she has been actively involved in the development of the new research facilities and curriculum.

Her research interests include pharmaceutical material science, preformulation and formulation of pharmaceuticals, amorphous solids, co-crystals, formulating poorly soluble drugs, pharmaceutical processing, pulmonary drug delivery and formulation stability.

Abina led the School of Pharmacy’s successful Athena Swan Bronze application in 2018 and is a member of the University’s Athena Swan Steering committee.

School of Chemical and Bioprocess Engineering, University College Dublin / Twitter: @Ferguson_UCD

'https://people.ucd.ie/steven.ferguson'

Dr Steven Ferguson graduated from UCD with a degree in Chemical & Bioprocess Engineering. He subsequently completed his PhD research in continuous crystallization of drugs as part of the SSPC Research Cluster. Steven has held positions in industry with the Novartis-MIT Center for Continuous Manufacturing in the USA. Steven later worked for Biogen where he developed novel clinical forms for first in class drugs in collaboration with pharmaceutical sciences and engage in the development of flow synthesis and continuous manufacturing technologies.

Steven returned to UCD as Assistant Professor in Chemical and Bioprocess Engineering. His research group focuses on drug delivery, separations and advanced manufacturing of pharmaceuticals. He has assembled a multidisciplinary team with expertise in separation processes, downstream bioprocessing, process simulation, flow synthesis, unit operation & reactor design, crystallization and formulation; structured to be vertically integrated to bring fundamental insights from multiphase systems, reactions or separations, through simulations and prototypes to actionable technologies.

Lidia Tajber is Associate Professor in Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin and is currently the Director of Research for the School. Lidia first gained an M. Pharm. degree from Medical University of Silesia, Katowice, Poland (with first class honours, ranking 1st in her class) and then pursued her Ph.D. degree in the School of Pharmacy, Trinity College Dublin (completed in 2005). She holds a postgraduate diploma in quality improvement and completed "Research leaders" training.

Lidia has published 76 high quality peer-review papers and contributed to numerous international conference presentations. Her current h-index is 25. She is also a co-inventor on a number of patent applications including "A method of producing porous microparticles" and "A polymeric nanoparticle". In addition to being an active researcher, she contributes to undergraduate (Pharmaceutics and Pharmaceutical Technology module) and postgraduate (Preformulation, Formulation and Advanced Drug Delivery modules) teaching. She is part of the coordinating team for the MSc in Pharmaceutical Sciences course.

Dr Katie Ryan, Assistant Professor School of Pharmacy, University College Cork

'http://research.ucc.ie/profiles/C019/katieryan

Dr. Katie Ryan is a lecture in Pharmaceutics in the School of Pharmacy, University College Cork. She graduated with a degree in Pharmacy from Trinity College Dublin, in 2001. Upon completion of her degree she undertook her pre-registration training with Élan Pharma and at Waterford regional hospital. Thereafter, she went on to pursue a PhD in Pharmaceutics with Prof. Pat Deasy in the School of Pharmacy in Trinity, in area of novel excipients for topical drug delivery.

In 2006, Katie joined the School of Pharmacy at UCC where she teaches both undergraduate and postgraduate courses in the areas of formulation science, novel drug delivery systems and statistics. She has undertaken a number of research visits to Prof. David Mooney’s Bioengineering lab in Harvard University investigating cellular responses to biomaterials used in drug delivery and tissue engineering. In 2013, she spent her sabbatical leave in the Mooney lab researching novel biomaterial strategies to promote bone tissue regeneration.

Dr Elizabeth Topp, Chief Scientific Officer NIBRT, University College Dublin

https://www.nibrt.ie/research-profile/elizabeth-topp/

Liz holds a bachelor’s degree in chemical engineering (BChE) from the University of Delaware, a master’s degree in engineering (ME) from the University of Pennsylvania and a PhD in pharmaceutics from the University of Michigan. She began her academic career in the Department of Pharmaceutical Chemistry at the University of Kansas in Lawrence, Kansas. In 2009, she accepted an appointment as the Dane O. Kildsig Chair and Head of the Department of Industrial and Physical Pharmacy at Purdue University in West Lafayette, Indiana, a position she held until 2017. In 2019, Dr. Topp was appointed Chief Scientific Officer at NIBRT, maintaining her Purdue faculty appointment.

Liz’s research focuses on the formulation and stability of protein drugs, with an emphasis on peptides and proteins in the amorphous solid state. This fascinating but poorly-understood state of matter challenges conventional, “solution-state” understanding of the factors that control protein structure and reactivity. The work is also of practical importance, since many protein drugs are stored and/or marketed as amorphous solids.

Dr Ioscani Jiménez del Val, Assistant Professor in Bioprocess Engineering School of Chemical & Bioprocess Engineering, University College Dublin / Twi

'https://people.ucd.ie/ioscani.jimenezdelval/about/

Ioscani leads the Animal Cell Technology Group (ACTG) at the School of Chemical & Bioprocess Engineering, University College Dublin. UCD’s ACTG is a multidisciplinary team that combines advanced experimentation and computational strategies to optimise the production of biopharmaceuticals, including monoclonal antibodies (mAbs) and gene therapy viral vectors.

Experimentally, ACTG develops and deploys synthetic biology and metabolic engineering strategies to enhance the productivity and quality of biopharmaceuticals derived from cell culture processes. Computationally, ACTG works on developing multi-scale mathematical models that describe cell culture dynamics, therapeutic protein glycosylation, cellular metabolic fluxes and full-scale integrated bioprocesses.

Dr. Joey O Shea, Lecturer in Pharmaceutics School of Pharmacy, University College Cork

'http://research.ucc.ie/profiles/C019/joseph.oshea@ucc.ie'

Dr Joey O'Shea is a Lecturer in Pharmaceutics in the School of Pharmacy, University College Cork and Director of the MSc in Pharmaceutical Technology and Quality Systems. 

He completed his Bachelor of Pharmacy degree in UCC in 2012 and Master of Pharmacy degree in the Royal College of Surgeons in Ireland in 2013. Dr O'Shea completed his Ph.D. in the School of Pharmacy in UCC in 2018. The focus of his doctoral work was on the biopharmaceutical aspects of solid oral dose formulation performance and the predictive capacity of various in vitro, in vivo and in silico methods of characterisation for oral bio-enabling formulations. Following completion of his PhD, Dr O'Shea held numerous positions in the pharmaceutical industry in Ireland, including in formulation development, clinical and regulatory affairs and in process development and technical support. Dr O'Shea returned to academia in November 2019, taking up a role as Lecturer in Pharmaceutics in the School of Pharmacy, UCC. He is programme director of the MSc in Pharmaceutical Technology and Quality Systems, an online masters course designed to train graduates working in the pharmaceutical industry to become a Qualified Person (QP). He also teaches on the undergraduate M. Pharm. Programme and the postgraduate diploma in Pharmaceutical Regulatory Sciences. 

Dr. Helen Sheridan, Associate Professor School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin / Twitter: @TCDPharmacy

person Full Profile

Helen Sheridan B. Sc (UCD), PhD (UCD) is Associate Professor in Pharmacognosy and former Director of Research at the School of Pharmacy and Pharmaceutical Sciences (SoPPS) at Trinity College Dublin. She is an academic founder and director of the TCD centre for natural product research, NatPro. She is a Fellow of Trinity College Dublin and the Royal Society of Chemistry; a recipient of the TCD Provost’s award for teaching excellence and a recipient of the TCD Innovation Award for 'Societal Impact' in 2021. Helen has 86 publications including 7 international patents. She has graduated 33 PhD/ MSc students, and mentored 24 postdoctoral researchers. She currently has sixteen researchers in her group.

Dr. Deirdre D’Arcy, Associate Professor School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin / Twitter: @TCDPharmacy

person Full Profile

Dr. Deirdre D’Arcy qualified as a pharmacist in 1999. After initial training in clinical pharmacy, she commenced a PhD in pharmaceutical technology, in the area of hydrodynamic simulations and dissolution testing. She is currently Associate Professor in Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (TCD), Ireland.

Her research interests relate to hydrodynamics in dissolution testing, clinically relevant dissolution testing, clinical pharmacokinetics and pharmaceutical pedagogy.

Dr. Sonja Vucen, Lecturer School of Pharmacy, University College Cork

'http://research.ucc.ie/profiles/C019/svucen'

Dr. Sonja Vucen is a lecturer in Pharmaceutics in the School of Pharmacy, University College Cork (UCC). She graduated with a degree in Pharmacy from Medical Faculty University of Banja Luka, Bosnia in 2005. Upon completion of her degree she undertook her pre-registration training at the community pharmacy, and worked as a teaching assistant in Pharmaceutics at the University of Banja Luka. She subsequently completed her PhD research in the area of development novel pharmaceutical formulations for transdermal drug delivery at the Faculty of Pharmacy, University of Belgrade, Serbia.

Since joining the School of Pharmacy in UCC, first as a researcher in 2011 and then as a lecturer in 2014, Sonja has been actively involved in the number of academic-industry collaborative research projects. In addition to her research activities, she has contributed to development and teaching of both undergraduate and postgraduate courses in the area of pharmaceutical science and technology. She also holds a postgraduate certificate in Teaching and Learning for Higher Education from UCC and is a part of the coordinating team for the MSc in BioPharma Processing programmes.

Dr. Joanna McGouran, Assistant Professor School of Chemistry, Trinity College Dublin

'https://chemistry.tcd.ie/staff/jmcgoura/

Joanna obtained a 1st class MChem Degree from the University of Oxford. Following this she completed her D.Phil. entitled "Probing sugar-plant-soil signalling" at the University of Oxford with Professor Ben Davis. Joanna then worked as a postdoctoral researcher with Professor Benedikt Kessler in the Department of Medicine, where she created novel ubiquitin-based covalent capture probes and developed inhibitor screening assays. She returned to chemistry department at the University of Oxford in 2014 to work with Professor Tom Brown where her research focused on the study of DNA cross-link repair enzymes, developing new tools to study their selectivity and activity. 

Dr. Carsten Erhardt, Professor School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin

person Full Profile

Carsten is Professor in Pharmaceutics and Biopharmaceutics at the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin (TCD). In 2013, he was elected Fellow of TCD. Carsten’s research studies the disposition and epithelial transport of drugs following their administration to the lungs using in vitro and ex vivo models. Moreover, he is interested in molecular origins of airways disease. Carsten has edited 1 book and (co-) authored >110 peer-reviewed publications and over 250 abstracts. He is the recipient of honours and awards from the German Pharmaceutical Society (DPhG), American Physiological Society and Galenus Foundation.